Form 8-K - Current report:
SEC Accession No. 0000950103-24-017767
Filing Date
2024-12-13
Accepted
2024-12-13 16:42:51
Documents
14
Period of Report
2024-12-13
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp222024_8k.htm   iXBRL 8-K 37202
2 EXHIBIT 10.1 dp222024_ex1001.htm EX-10.1 1002935
  Complete submission text file 0000950103-24-017767.txt   1419900

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crl-20241213.xsd EX-101.SCH 2997
4 XBRL LABEL FILE crl-20241213_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE crl-20241213_pre.xml EX-101.PRE 22348
16 EXTRACTED XBRL INSTANCE DOCUMENT dp222024_8k_htm.xml XML 3580
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 241549020
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)